Expression of chemokine receptor CXCR3 by lymphocytes and plasmacytoid dendritic cells in human psoriatic lesions

Archives of Dermatological Research

Volumn 302, Issue 2, 2010, Pages 113-123

  Chen, Shu Cheng ^a   De Groot, Marjan ^b   Kinsley, David ^a   Laverty, Maureen ^a   McClanahan, Terrill ^a   Arreaza, Maria ^a   Gustafson, Eric L ^a   Teunissen, Marcel B M ^b   De Rie, Menno A ^b,c   Fine, Jay S ^a,d   Kraan, Maarten ^a,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NOVARTIS PHARMA AG   (Switzerland)

^d HOFFMANN LA ROCHE INC   (United States)

Author keywords

Chemokine; CXCR3; Plasmacytoid dendritic cells; Psoriasis; Trafficking

Indexed keywords

BDCA2 ANTIGEN; CD68 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG; CXCR3 PROTEIN, HUMAN; MESSENGER RNA;

ARTICLE; BONE MARROW CELL; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; CELL COUNT; DRUG ANTAGONISM; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LYMPHOCYTE; PATHOLOGY; PHYSIOLOGY; PSORIASIS; SKIN;

CELL COUNT; DENDRITIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; PSORIASIS; RECEPTORS, CXCR3; RNA, MESSENGER; SKIN;

EID: 77449145700     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0966-2     Document Type: Article

References (54)

1. C Albanesi C Scarponi S Pallotta R Daniele D Bosisio S Madonna P Fortugno S Gonzalvo-Feo JD Franssen M Parmentier O De Pita G Girolomoni S Sozzani 2009 Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment J Exp Med 206 249 258 10.1084/jem.20080129 10.1084/jem.20080129 1:CAS:528:DC%2BD1MXhtVOhu74%3D 19114666
2. Berry K, Friedrich M, Kersey K, Stempien MJ, Wagner F, van Lier JJ, Sabat R, Wolk K (2004) Evaluation of T0906487, a CXCR3 antagonist, in a phase 2 psoriasis trial. In: Inflammation research association annual meeting
3. JR Bjerke HK Krogh R Matre 1978 Characterization of mononuclear cell infiltrates in psoriatic lesions J Invest Dermatol 71 340 343 10.1111/1523-1747.ep12529841 10.1111/1523-1747.ep12529841 1:STN:280: DyaE1M%2FkvFejsQ%3D%3D 309493
4. HJ Bovenschen MM Seyger PC Van de Kerkhof 2005 Plaque psoriasis vs atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation Br J Dermatol 153 72 78 10.1111/j.1365-2133.2005.06538.x 10.1111/j.1365-2133.2005.06538.x 1:STN:280:DC%2BD2MzntFyksw%3D%3D 16029329 (Pubitemid 41044530)
5. O Boyman HP Hefti C Conrad BJ Nickoloff M Suter FO Nestle 2004 Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha J Exp Med 199 731 736 10.1084/jem.20031482 10.1084/jem.20031482 1:CAS:528:DC%2BD2cXitFyjtL8%3D 14981113 (Pubitemid 38316440)
6. JR Chan W Blumenschein E Murphy C Diveu M Wiekowski S Abbondanzo L Lucian R Geissler S Brodie AB Kimball DM Gorman K Smith R de Waal Malefyt RA Kastelein TK McClanahan EP Bowman 2006 IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis J Exp Med 203 2577 2587 10.1084/jem.20060244 10.1084/jem.20060244 1:CAS:528:DC%2BD28Xht12htLbL 17074928 (Pubitemid 44833335)
7. C Conrad O Boyman G Tonel A Tun-Kyi U Laggner A de Fougerolles V Kotelianski H Gardner FO Nestle 2007 Alpha 1 beta 1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis Nat Med 13 836 842 10.1038/nm1605 10.1038/nm1605 1:CAS:528:DC%2BD2sXnsFWmtrc%3D 17603494 (Pubitemid 47038192)
8. MA Cox CH Jenh W Gonsiorek J Fine SK Narula PJ Zavodny RW Hipkin 2001 Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states Mol Pharmacol 59 707 715 1:CAS:528: DC%2BD3MXisVSru7c%3D 11259614
9. CN Ellis MS Fradin JM Messana MD Brown MT Siegel AH Hartley LL Rocher S Wheeler TA Hamilton TG Parish, et al. 1991 Cyclosporine for plaque-type psoriasis: results of a multidose, double-blind trial N Engl J Med 324 277 284 1:STN:280:DyaK3M%2FpsV2ltA%3D%3D 1986287
10. KW Eriksen P Lovato L Skov T Krejsgaard K Kaltoft C Geisler N Odum 2005 Increased sensitivity to interferon-alpha in psoriatic T cells J Invest Dermatol 125 936 944 1:CAS:528:DC%2BD2MXht1Grtr3K 16297193
11. J Flier DM Boorsma PJ van Beek C Nieboer TJ Stoof R Willemze CP Tensen 2001 Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation J Pathol 194 398 405 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S 10.1002/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S 1:CAS:528:DC%2BD3MXmslWku70%3D 11523046
12. MA Garcia-Lopez F Sanchez-Madrid JM Rodriguez-Frade M Mellado A Acevedo MI Garcia JP Albar C Martinez M Marazuela 2001 CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells Lab Invest 81 409 418 1:CAS:528:DC%2BD3MXivVKqsbY%3D 11310833
13. A Gilhar M David Y Ullmann T Berkutski RS Kalish 1997 T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice J Invest Dermatol 109 283 288 10.1111/1523-1747.ep12335758 10.1111/1523-1747. ep12335758 1:STN:280:DyaK2svisl2jsQ%3D%3D 9284091
14. M Gilliet C Conrad M Geiges A Cozzio W Thurlimann G Burg FO Nestle R Dummer 2004 Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors Arch Dermatol 140 1490 1495 10.1001/archderm.140.12.1490 10.1001/archderm.140.12.1490 1:CAS:528:DC%2BD2MXjslSjtw%3D%3D 15611427 (Pubitemid 39627441)
15. AY Goedkoop MA de Rie MB Teunissen DI Picavet PO van der Hall JD Bos PP Tak MC Kraan 2005 Digital image analysis for the evaluation of the inflammatory infiltrate in psoriasis Arch Dermatol Res 297 51 59 10.1007/s00403-005-0578-4 10.1007/s00403-005-0578-4 16012877 (Pubitemid 41431543)
16. AB Gottlieb AD Luster DN Posnett DM Carter 1988 Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques J Exp Med 168 941 948 10.1084/jem.168.3.941 10.1084/jem.168.3.941 1:CAS:528:DyaL1cXlvVymsL8%3D 2459293 (Pubitemid 18244122)
17. AB Gottlieb 2005 Psoriasis: emerging therapeutic strategies Nat Rev Drug Discov 42 19 34 10.1038/nrd1607 10.1038/nrd1607 (Pubitemid 40109587)
18. SL Gottlieb P Gilleaudeau R Johnson L Estes TG Woodworth AB Gottlieb JG Krueger 1995 Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis Nat Med 1 442 447 10.1038/nm0595-442 10.1038/nm0595-442 1:CAS:528:DyaK2MXls1SgtLw%3D 7585092
19. R Horuk 2009 Chemokine receptor antagonists: overcoming developmental hurdles Nat Rev Drug Discov 8 23 33 10.1038/nrd2734 10.1038/nrd2734 1:CAS:528:DC%2BD1MXpt12j 19079127
20. W Iijima H Ohtani T Nakayama Y Sugawara E Sato H Nagura O Yoshie T Sasano 2003 Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism Am J Pathol 163 261 268 1:CAS:528:DC%2BD3sXmtVWrtbg%3D 12819030
21. D Jones RJ Benjamin A Shahsafaei DM Dorfman 2000 The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia Blood 95 627 632 1:CAS:528:DC%2BD3cXlsFGhug%3D%3D 10627472
22. T Kallinich S Schmidt E Hamelmann A Fischer S Qin W Luttmann JC Virchow RA Kroczek 2005 Chemokine-receptor expression on T cells in lung compartments of challenged asthmatic patients Clin Exp Allergy 35 26 33 10.1111/j.1365-2222. 2004.02132.x 10.1111/j.1365-2222.2004.02132.x 1:CAS:528:DC%2BD2MXhs1CisL8%3D 15649262 (Pubitemid 40188266)
23. F Kazazi JM Mathijs P Foley AL Cunningham 1989 Variations in CD4 expression by human monocytes and macrophages and their relationships to infection with the human immunodeficiency virus J Gen Virol 70 Pt 10 2661 2672 10.1099/0022-1317-70-10-2661 10.1099/0022-1317-70-10-2661 1:CAS:528: DyaL1MXmtlSnt70%3D 2677236
24. N Kohrgruber M Groger P Meraner E Kriehuber P Petzelbauer S Brandt G Stingl A Rot D Maurer 2004 Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands J Immunol 173 6592 6602 1:CAS:528:DC%2BD2cXhtVShsLfI 15557149
25. EJ Kunkel J Boisvert K Murphy MA Vierra MC Genovese AJ Wardlaw HB Greenberg MR Hodge L Wu EC Butcher JJ Campbell 2002 Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes Am J Pathol 160 347 355 1:CAS:528:DC%2BD38XnvFensA%3D%3D 11786428
26. R Lande J Gregorio V Facchinetti B Chatterjee YH Wang B Homey W Cao B Su FO Nestle T Zal I Mellman JM Schroder YJ Liu M Gilliet 2007 Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide Nature 449 564 569 10.1038/nature06116 10.1038/nature06116 1:CAS:528:DC%2BD2sXhtFagtL7K 17873860 (Pubitemid 47525141)
27. CL Langrish Y Chen WM Blumenschein J Mattson B Basham JD Sedgwick T McClanahan RA Kastelein DJ Cua 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation J Exp Med 201 233 240 10.1084/jem.20041257 10.1084/jem.20041257 1:CAS:528:DC%2BD2MXot12mtA%3D%3D 15657292 (Pubitemid 40189432)
28. IM Leigh H Navsaria PE Purkis IA McKay PE Bowden PN Riddle 1995 Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro Br J Dermatol 133 501 511 10.1111/j.1365-2133.1995.tb02696.x 10.1111/j.1365-2133.1995.tb02696.x 1:STN:280:DyaK28%2Fps1yntQ%3D%3D 7577575
29. J Li D Li Z Tan 2004 The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris J Huazhong Univ Sci Technol Med Sci 24 294 296 1:CAS:528: DC%2BD2cXmtl2itr4%3D 15315354
30. MA Lowes F Chamian MV Abello J Fuentes-Duculan SL Lin R Nussbaum I Novitskaya H Carbonaro I Cardinale T Kikuchi P Gilleaudeau M Sullivan-Whalen KM Wittkowski K Papp M Garovoy W Dummer RM Steinman JG Krueger 2005 Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a) Proc Natl Acad Sci USA 102 19057 19062 10.1073/pnas.0509736102 10.1073/pnas.0509736102 1:CAS:528: DC%2BD28XivV2hsQ%3D%3D 16380428 (Pubitemid 43049565)
31. MA Lowes T Kikuchi J Fuentes-Duculan I Cardinale LC Zaba AS Haider EP Bowman JG Krueger 2008 Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells J Invest Dermatol 128 1207 1211 10.1038/sj.jid.5701213 10.1038/sj.jid.5701213 1:CAS:528:DC%2BD1cXksFyhsbs%3D 18200064 (Pubitemid 351543220)
32. S Meller F Winterberg M Gilliet A Muller I Lauceviciute J Rieker NJ Neumann R Kubitza M Gombert E Bunemann U Wiesner P Franken-Kunkel H Kanzler MC Dieu-Nosjean A Amara T Ruzicka P Lehmann A Zlotnik B Homey 2005 Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus Arthritis Rheum 52 1504 1516 10.1002/art.21034 10.1002/art.21034 1:CAS:528:DC%2BD2MXkvFCisrw%3D 15880822 (Pubitemid 40663942)
33. G Muehlinghaus L Cigliano S Huehn A Peddinghaus H Leyendeckers AE Hauser F Hiepe A Radbruch S Arce RA Manz 2005 Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells Blood 105 3965 3971 10.1182/blood-2004-08-2992 10.1182/blood-2004-08-2992 1:CAS:528:DC%2BD2MXktlSrsbk%3D 15687242 (Pubitemid 40656144)
34. FO Nestle C Conrad A Tun-Kyi B Homey M Gombert O Boyman G Burg YJ Liu M Gilliet 2005 Plasmacytoid pre-dendritic cells initiate psoriasis through interferon-alpha production J Exp Med 202 135 143 10.1084/jem.20050500 10.1084/jem.20050500 1:CAS:528:DC%2BD2MXmtVaqsbc%3D 15998792 (Pubitemid 41002916)
35. BJ Nickoloff T Wrone-Smith 1999 Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis Am J Pathol 155 145 158 1:STN:280: DyaK1MzisVejtQ%3D%3D 10393847
36. E Ocana L Delgado-Perez A Campos-Caro J Munoz A Paz R Franco JA Brieva 2007 The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells Haematologica 92 349 356 10.3324/haematol.10649 10.3324/haematol.10649 17339184 (Pubitemid 350143544)
37. B Oppmann R Lesley B Blom JC Timans Y Xu B Hunte F Vega N Yu J Wang K Singh F Zonin E Vaisberg T Churakova M Liu D Gorman J Wagner S Zurawski Y Liu JS Abrams KW Moore D Rennick R de Waal-Malefyt C Hannum JF Bazan RA Kastelein 2000 Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 13 715 725 10.1016/S1074-7613(00)00070-4 10.1016/S1074-7613(00)00070-4 1:CAS:528: DC%2BD3cXovV2ht7c%3D 11114383
38. G Piskin RM Sylva-Steenland JD Bos MB Teunissen 2006 In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin J Immunol 176 1908 1915 1:CAS:528:DC%2BD28XlsFyktA%3D%3D 16424222
39. JC Prinz B Gross S Vollmer P Trommler I Strobel M Meurer G Plewig 1994 T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products Eur J Immunol 24 593 598 10.1002/eji.1830240315 10.1002/eji.1830240315 1:CAS:528:DyaK2cXitFGisbk%3D 8125129
40. S Qin JB Rottman P Myers N Kassam M Weinblatt M Loetscher AE Koch B Moser CR Mackay 1998 The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions J Clin Invest 101 746 754 10.1172/JCI1422 10.1172/JCI1422 1:CAS:528:DyaK1cXht1Wrsbk%3D 9466968
41. JB Rottman TL Smith KG Ganley T Kikuchi JG Krueger 2001 Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alpha Ebeta7 in the pathogenesis of psoriasis vulgaris Lab Invest 81 335 347 1:CAS:528: DC%2BD3MXivVKqsLo%3D 11310827
42. P Schmid P Itin D Cox GK McMaster MA Horisberger 1994 The type I interferon system is locally activated in psoriatic lesions J Interferon Res 14 229 234 1:CAS:528:DyaK2cXmslyksLo%3D 7861026
43. J Skrzeczynska-Moncznik K Wawro A Stefanska E Oleszycka P Kulig BA Zabel M Sulkowski M Kapinska-Mrowiecka M Czubak-Macugowska EC Butcher J Cichy 2009 Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin Biochem Biophys Res Commun 380 323 327 10.1016/j.bbrc.2009.01.071 10.1016/j.bbrc.2009.01.071 1:CAS:528:DC%2BD1MXitlajs7w%3D 19168032
44. Y Teraki A Miyake R Takebayashi T Shiohara 2004 Homing receptor and chemokine receptor on intraepidermal T cells in psoriasis vulgaris Clin Exp Dermatol 29 658 663 10.1111/j.1365-2230.2004.01638.x 10.1111/j.1365-2230.2004. 01638.x 1:STN:280:DC%2BD2crotVOjtA%3D%3D 15550147 (Pubitemid 39573660)
45. MB Teunissen CW Koomen R de Waal Malefyt EA Wierenga JD Bos 1998 Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes J Invest Dermatol 111 645 649 10.1046/j.1523-1747.1998.00347.x 10.1046/j.1523-1747.1998.00347.x 1:CAS:528:DyaK1cXmtlyjtrk%3D 9764847 (Pubitemid 28452327)
46. SY Thomas A Banerji BD Medoff CM Lilly AD Luster 2007 Multiple chemokine receptors, including CCR6 and CXCR3, regulate antigen-induced T cell homing to the human asthmatic airway J Immunol 179 1901 1912 1:CAS:528: DC%2BD2sXnvVyms7g%3D 17641057
47. L van der Fits LI van der Wel JD Laman EP Prens MC Verschuren 2004 In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered J Invest Dermatol 122 51 60 10.1046/j.0022-202X.2003.22113.x 10.1046/j.0022-202X.2003.22113.x 14962089 (Pubitemid 38114638)
48. B Vanbervliet N Bendriss-Vermare C Massacrier B Homey O de Bouteiller F Briere G Trinchieri C Caux 2003 The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12 J Exp Med 198 823 830 10.1084/jem.20020437 10.1084/jem.20020437 1:CAS:528:DC%2BD3sXntFeqtLw%3D 12953097 (Pubitemid 37087780)
49. J Wenzel M Uerlich O Haller T Bieber T Tueting 2005 Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod J Cutan Pathol 32 257 262 10.1111/j.0303-6987.2005.00297.x 10.1111/j.0303-6987. 2005.00297.x 15769273 (Pubitemid 40459926)
50. J Wenzel A Wiechert C Merkel T Bieber T Tuting 2007 IP10/CXCL10-CXCR3 interaction: a potential self-recruiting mechanism for cytotoxic lymphocytes in lichen Sclerosus atrophicus Acta Derm Venereol 87 112 117 10.2340/00015555-0194 10.2340/00015555-0194 17340016 (Pubitemid 46513195)
51. J Wenzel B Peters S Zahn M Birth K Hofmann D Kusters S Tomiuk JM Baron HF Merk C Mauch T Krieg T Bieber T Tuting A Bosio 2008 Gene expression profiling of lichen planus reflects CXCL9+-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis J Invest Dermatol 128 67 78 10.1038/sj.jid.5700945 10.1038/sj.jid.5700945 1:CAS:528:DC%2BD2sXhsVSksbjI 17703176 (Pubitemid 350249372)
52. M Wijtmans D Verzijl R Leurs IJ de Esch MJ Smit 2008 Towards small-molecule CXCR3 ligands with clinical potential Chem Med Chem 3 861 872 10.1002/cmdc.200700365 1:CAS:528:DC%2BD1cXnvVWmt7w%3D 18442035
53. T Wrone-Smith BJ Nickoloff 1996 Dermal injection of immunocytes induces psoriasis J Clin Invest 98 1878 1887 10.1172/JCI118989 10.1172/JCI118989 1:CAS:528:DyaK28XmtlOrsrc%3D 8878440
54. J Yamamoto Y Adachi Y Onoue YS Adachi Y Okabe T Itazawa M Toyoda T Seki M Morohashi K Matsushima T Miyawaki 2000 Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells J Leukoc Biol 68 568 574 1:CAS:528:DC%2BD3cXnsVShu7s%3D 11037980